Monoclonal antibody which binds ENTPD1, and reacts with Epstein Barr lymphoblastoid cell lines.
| Inventor | Institute |
|---|---|
| Martin Rowe | University of Birmingham |
| Cat. #: | 151580 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Cell biology;Immunology;Neurobiology;Tissue-specific biology |
| Application: | FACS ; IF ; IP ; WB |
| Target: | Ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD1, CD39) |
| Reactivity: | Human |
| Clone: | AC2 |
| Host: | Mouse |
| Class: | Monoclonal |
| Primary citation: | Rowe et al. 1982. Int J Cancer. 29(4):373-81. PMID: 6282762. |
| Product description: | Monoclonal antibody which binds ENTPD1, and reacts with Epstein Barr lymphoblastoid cell lines. ACE2 reacted consistently with all Epstein Barr virus lymphoblastoid cell line (EB-LCL) tested, with a subpopulation of cells in some but not all EB virus genome-positive Burkitt lymphoma lines, but with none of a range of EB virus genome-negative cell lines of lymphoma or leukaemia origin. |
|---|---|
| Conjugation: | Unconjugated |
| Isotype: | IgG1 |
| Molecular weight: | 70-100 kDa |
| Immunogen: | EBV-transformed human B lymphoblastoid cell line |
| Immunogen Uniprot ID: | O75356 |
| Myeloma used: | P3X63Ag8.653 |
| Target background: | ENTPD1 is a transmembrane glycoprotein of apparent molecular weight of 70-100 kD that has an Ectonucleoside triphosphate diphosphohydrolase-1 (NTPDase-1, ecto-apyrase) activity hydrolysing the alpha- and beta- phosphate residues of extracellular ATP or ADP. In haematopoietic tissues, it is primarily expressed on activated B, T and NK cells. It is also expressed on some endothelial cells and cardiac neurons, and helps regulate platelet activation, vascular inflammation, and cardiac norepinephrine release. |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | Store at -20° C frozen. Avoid repeated freeze / thaw cycles |
| Shipping conditions: | Dry ice |
| References: |
Rowe et al. 1982. Int J Cancer. 29(4):373-81. PMID: 6282762. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151015 | Anti-CyclinA [E70.1] |
Key Info
Anti-CyclinA [E70.1]
|
View Tool | |||||||||||||||||||
| 151021 | Anti-CyclinB1 [V152] |
Key Info
Anti-CyclinB1 [V152]
|
View Tool | |||||||||||||||||||
| 151023 | Anti-IL12 [1-1D5] |
Key Info
Anti-IL12 [1-1D5]
|
View Tool | |||||||||||||||||||
| 151024 | Anti-Hairy [1/24] |
Key Info
Anti-Hairy [1/24]
|
View Tool | |||||||||||||||||||
| 151031 | Anti-RuvA [RuvA 12C6] |
Key Info
Anti-RuvA [RuvA 12C6]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.